Sarepta Therapeutics (SRPT) Lags Q4 Earnings Estimates
Portfolio Pulse from
Sarepta Therapeutics (SRPT) reported Q4 earnings of $1.50 per share, missing the Zacks Consensus Estimate of $1.87. This is an improvement from $0.47 per share a year ago.
February 26, 2025 | 11:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Sarepta Therapeutics reported Q4 earnings of $1.50 per share, missing the expected $1.87. Despite the miss, earnings improved from $0.47 a year ago.
The earnings miss is likely to negatively impact SRPT's stock price in the short term as it fell short of analyst expectations. However, the year-over-year improvement in earnings per share may mitigate some negative sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100